Join FLASCO for Part I of Updates in IDHm Gliomas with FLASCO Neuro-Oncology Captain, Ashley Ghiaseddin, MD, FAAN. This informative podcast covers current and emerging treatments, the evolving role of IDH inhibitors, and the key challenges in treatment, including resistance and tumor heterogeneity. Whether you’re a clinician, researcher, or oncology professional, this FLASCO OncoPod provides valuable insights to enhance patient care and clinical strategies. Listen now to stay at the forefront of glioma treatment advancements!